A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face

NCT05784363 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Enlarged Pores
Sebum Production

Interventions

DRUG: NT 201
DRUG: Placebo

Sponsor

Merz North America, Inc.